相关视频 -

¹Afdeling for Kræftbehandling, Københavns Universitetshospital - Rigshospitalet.

Ugeskrift for laeger

|March 27, 2024

概括

早期乳腺癌的辅助和新辅助疗法显著降低了复发风险和死亡率. 治疗选择是个性化的,使用风险模型和多学科审查,以获得最佳的患者益处.

科学领域:

在瘤学瘤学.
临床医学临床医学

背景情况:

辅助和新辅助疗法对于早期乳腺癌至关重要,旨在减少复发和死亡率.

相关概念视频

您也可能阅读

通过共同作者、期刊和引用图与本文相关的文章。

排序

Same author

Outcomes for patients with high-risk ER-positive, HER2-negative early-stage breast cancer: a Danish real-world study.

Acta oncologica (Stockholm, Sweden)·2025

Same author

Real-world efficacy of tucatinib in Danish human epidermal growth factor receptor 2-positive metastatic breast cancer.

Danish medical journal·2025

Same author

A direct comparison of classical oral Navelbine vs metronomic Navelbine in metastatic breast cancer: results from the Danish Breast Cancer Group's (DBCG) NAME-trial.

Breast cancer research and treatment·2025

相关实验视频

相关概念视频

Outcomes for patients with high-risk ER-positive, HER2-negative early-stage breast cancer: a Danish real-world study.

Real-world efficacy of tucatinib in Danish human epidermal growth factor receptor 2-positive metastatic breast cancer.

A direct comparison of classical oral Navelbine vs metronomic Navelbine in metastatic breast cancer: results from the Danish Breast Cancer Group's (DBCG) NAME-trial.

Chronic chemotherapy-induced peripheral neuropathy and pain following paclitaxel versus docetaxel in breast cancer survivors: A cross-sectional study.

Real-world effectiveness of CDK 4/6 inhibitors in estrogen-positive metastatic breast cancer.

相关实验视频

相关概念视频

Outcomes for patients with high-risk ER-positive, HER2-negative early-stage breast cancer: a Danish real-world study.

Real-world efficacy of tucatinib in Danish human epidermal growth factor receptor 2-positive metastatic breast cancer.

A direct comparison of classical oral Navelbine vs metronomic Navelbine in metastatic breast cancer: results from the Danish Breast Cancer Group's (DBCG) NAME-trial.

Chronic chemotherapy-induced peripheral neuropathy and pain following paclitaxel versus docetaxel in breast cancer survivors: A cross-sectional study.

Real-world effectiveness of CDK 4/6 inhibitors in estrogen-positive metastatic breast cancer.

相关实验视频

科学领域:

背景情况:

结论:

相关概念视频

相关文章

Outcomes for patients with high-risk ER-positive, HER2-negative early-stage breast cancer: a Danish real-world study.

Real-world efficacy of tucatinib in Danish human epidermal growth factor receptor 2-positive metastatic breast cancer.

A direct comparison of classical oral Navelbine vs metronomic Navelbine in metastatic breast cancer: results from the Danish Breast Cancer Group's (DBCG) NAME-trial.

Chronic chemotherapy-induced peripheral neuropathy and pain following paclitaxel versus docetaxel in breast cancer survivors: A cross-sectional study.

Real-world effectiveness of CDK 4/6 inhibitors in estrogen-positive metastatic breast cancer.

相关实验视频

科学领域:

背景情况:

结论:

相关概念视频

相关文章

Outcomes for patients with high-risk ER-positive, HER2-negative early-stage breast cancer: a Danish real-world study.

Real-world efficacy of tucatinib in Danish human epidermal growth factor receptor 2-positive metastatic breast cancer.

A direct comparison of classical oral Navelbine vs metronomic Navelbine in metastatic breast cancer: results from the Danish Breast Cancer Group's (DBCG) NAME-trial.

Chronic chemotherapy-induced peripheral neuropathy and pain following paclitaxel versus docetaxel in breast cancer survivors: A cross-sectional study.

Real-world effectiveness of CDK 4/6 inhibitors in estrogen-positive metastatic breast cancer.